» Articles » PMID: 35909883

Multiphysics Pharmacokinetic Model for Targeted Nanoparticles

Overview
Date 2022 Aug 1
PMID 35909883
Authors
Affiliations
Soon will be listed here.
Abstract

Nanoparticles (NP) are being increasingly explored as vehicles for targeted drug delivery because they can overcome free therapeutic limitations by drug encapsulation, thereby increasing solubility and transport across cell membranes. However, a translational gap exists from animal to human studies resulting in only several NP having FDA approval. Because of this, researchers have begun to turn toward physiologically based pharmacokinetic (PBPK) models to guide NP experimentation. However, typical PBPK models use an empirically derived framework that cannot be universally applied to varying NP constructs and experimental settings. The purpose of this study was to develop a physics-based multiscale PBPK compartmental model for determining continuous NP biodistribution. We successfully developed two versions of a physics-based compartmental model, models A and B, and validated the models with experimental data. The more physiologically relevant model (model B) had an output that more closely resembled experimental data as determined by normalized root mean squared deviation (NRMSD) analysis. A branched model was developed to enable the model to account for varying NP sizes. With the help of the branched model, we were able to show that branching in vasculature causes enhanced uptake of NP in the organ tissue. The models were solved using two of the most popular computational platforms, MATLAB and Julia. Our experimentation with the two suggests the highly optimized ODE solver package DifferentialEquations.jl in Julia outperforms MATLAB when solving a stiff system of ordinary differential equations (ODEs). We experimented with solving our PBPK model with a neural network using Julia's Flux.jl package. We were able to demonstrate that a neural network can learn to solve a system of ODEs when the system can be made non-stiff quasi-steady-state approximation (QSSA). Our model incorporates modules that account for varying NP surface chemistries, multiscale vascular hydrodynamic effects, and effects of the immune system to create a more comprehensive and modular model for predicting NP biodistribution in a variety of NP constructs.

Citing Articles

Mathematical complexities in radionuclide metabolic modelling: a review of ordinary differential equation kinetics solvers in biokinetic modelling.

Mate-Kole E, Dewji S J Radiol Prot. 2024; 44(2).

PMID: 38324906 PMC: 11214694. DOI: 10.1088/1361-6498/ad270d.


Para- and Transcellular Transport Kinetics of Nanoparticles across Lymphatic Endothelial Cells.

McCright J, Yarmovsky J, Maisel K Mol Pharm. 2023; 21(3):1160-1169.

PMID: 37851841 PMC: 10923144. DOI: 10.1021/acs.molpharmaceut.3c00720.


Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis Tools.

Kutumova E, Akberdin I, Kiselev I, Sharipov R, Egorova V, Syrocheva A Int J Mol Sci. 2022; 23(20).

PMID: 36293410 PMC: 9604366. DOI: 10.3390/ijms232012560.

References
1.
Agrawal N, Radhakrishnan R . The Role of Glycocalyx in Nanocarrier-Cell Adhesion Investigated Using a Thermodynamic Model and Monte Carlo Simulations. J Phys Chem C Nanomater Interfaces. 2008; 111(43):15848-15856. PMC: 2600419. DOI: 10.1021/jp074514x. View

2.
Zhang X, Trame M, Lesko L, Schmidt S . Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology Models. CPT Pharmacometrics Syst Pharmacol. 2016; 4(2):69-79. PMC: 5006244. DOI: 10.1002/psp4.6. View

3.
Anselmo A, Mitragotri S . Nanoparticles in the clinic. Bioeng Transl Med. 2018; 1(1):10-29. PMC: 5689513. DOI: 10.1002/btm2.10003. View

4.
Farokhirad S, Kutti Kandy S, Tsourkas A, Ayyaswamy P, Eckmann D, Radhakrishnan R . Biophysical Considerations in the Rational Design and Cellular Targeting of Flexible Polymeric Nanoparticles. Adv Mater Interfaces. 2022; 8(23). PMC: 9248849. DOI: 10.1002/admi.202101290. View

5.
Mitragotri S, Lammers T, Bae Y, Schwendeman S, De Smedt S, Leroux J . Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond. J Control Release. 2017; 246:183-184. DOI: 10.1016/j.jconrel.2017.01.011. View